Regulators suspend review of Landmark purchase

STATE REGULATORS HAVE suspended their review of Prime Healthcare's bid to buy Landmark Medical Center until the applicant can provide more clarifying information. / PBN FILE PHOTO/DAVID LEVESQUE
STATE REGULATORS HAVE suspended their review of Prime Healthcare's bid to buy Landmark Medical Center until the applicant can provide more clarifying information. / PBN FILE PHOTO/DAVID LEVESQUE

PROVIDENCE — State regulators have suspended their review of Prime Healthcare Service’s application to buy Landmark Medical Center until the applicant can provide additional clarifying information, according to Amy Kempe, spokeswoman for the R.I. Attorney General’s office.

In a letter dated March 29 to lawyers representing Landmark and Prime, regulators said that they were doing suspending their review in order to conserve state resources and to insure that the application can reach a successful conclusion.

More information will be forthcoming from regulators detailing the additional information next week, according to the letter.

Regulators marked the Ontario, Calif.-based hospital network’s application incomplete in early February.

- Advertisement -

No posts to display